Design and total synthesis of Mannich derivatives of marine natural product lamellarin D as cytotoxic agents

Eur J Med Chem. 2014 Oct 6:85:807-17. doi: 10.1016/j.ejmech.2014.08.038. Epub 2014 Aug 12.

Abstract

Enlightened by the modification route from Camptothecin (CPT) to Topotecan and based on classical drug design theory, a series of Mannich derivatives of lamellarin D were designed and synthesized in 26-27 steps starting from vanillin and isovanilin. All synthesized compounds were then biologically evaluated for their in vitro anti-cancer activities and Topo I inhibitory activities. The results showed that most target compounds exhibited Topo I inhibitory activities in equivalent level with that of lamellarin D. Compound SL-9 exhibited better Topo I inhibitory activity than that of lamellarin D. Compounds SL-2, SL-3, SL-4, SL-5 and SL-11 exhibited better anti-proliferative activity against HT-29 cells than that of lamellarin D.

Keywords: Anti-cancer; Derivative; Lamellarin D; Mannich; Structure–activity relationships; Topo I.

MeSH terms

  • Alkylation
  • Aquatic Organisms / chemistry*
  • Biological Products / chemical synthesis*
  • Biological Products / chemistry
  • Biological Products / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Chemistry Techniques, Synthetic
  • Coumarins / chemical synthesis*
  • Coumarins / chemistry
  • Coumarins / pharmacology*
  • DNA Topoisomerases, Type I / metabolism
  • Drug Design*
  • Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
  • Heterocyclic Compounds, 4 or More Rings / chemistry
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Humans
  • Isoquinolines / chemical synthesis*
  • Isoquinolines / chemistry
  • Isoquinolines / pharmacology*
  • Topoisomerase I Inhibitors / chemical synthesis
  • Topoisomerase I Inhibitors / chemistry
  • Topoisomerase I Inhibitors / pharmacology

Substances

  • Biological Products
  • Coumarins
  • Heterocyclic Compounds, 4 or More Rings
  • Isoquinolines
  • Topoisomerase I Inhibitors
  • lamellarin D
  • DNA Topoisomerases, Type I